BLUM ROBERT I (President & CEO) sold 2.6% of their position (7.50K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $490.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/28/2026ACC: 0001061983-26-000097
DirectorOfficer· President & CEO
Since Jul 2018
-7.50K
Net shares
Net seller
$490.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.50K acquired · 15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.50K
Price / share
$10.60
Trade value
$79.50K
% of position
2.7%
9/28/2026
278.54K→286.04K
Common Stock
Direct
Shares
−7.50K
Price / share
$65.46
Trade value
$490.95K
% of position
2.6%
9/28/2026
286.04K→278.54K
Total
Net shares
+0.00
Net value
-$411.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/28/2026 | M · Option Exercise | +7.50K | $10.60 | $79.50K | 2.7% | 278.54K | 286.04K |
| Common Stock Direct | 9/28/2026 | S · Sale | −7.50K | $65.46 | $490.95K | 2.6% | 286.04K | 278.54K |
| Total | +0.00 | -$411.45K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.50K shares
Shares
−7.50K
Strike price
10.60
Held after
149.25K
Exercisable
—
9/28/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) Direct | Common Stock7.50K shares | 9/28/2026 | M · Option Exercise | −7.50K | 10.60 | — | 149.25K |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned2.08K
Common Stock
IndirectShares owned2.08K
Common Stock
IndirectShares owned0.00
Total
4.17K indirect4.17K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.08K | Indirect |
| Common Stock | 2.08K | Indirect |
| Common Stock | 0.00 | Indirect |
| Total | 4.17K | 4.17K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported